Skip to main content

Madhu Rewari and Nivodita Sharma assisted India’s largest manufacturer and exporter of beverages, in successfully concluding its business collaboration with India’s largest media conglomerate.

The team played a crucial role in formalising the multifaceted collaboration encompassing the goodwill of the two majors, deploying a mix of the advertising supremacies and mass consumer base.

The team advised the client in instituting this collaboration and evaluating various risks involved in subscription of shares and warrants in the new company. The team incorporated potentially approving provisions in the relevant documents to avoid any complicated maze. As a part of the complex arrangement, an Advertisement Agreement was drafted channelizing the funds towards various modes of advertisements and created a smooth Line of Credit in the agreement.

In the course of finalising the transaction, the team advised the client on delicate issues relating to exercise of warrants, ownership of rights in intellectual property, favourable non-compete, Right of First Refusal, Tag-along rights, Drag-along rights, discharge of Line of Credit, tranches of advertisement release and severance.

In relation to the above and other points of concern, the team contributed many rounds of discussions with the legal and business team of the other party and reviewed, revised and negotiated the best of the interest of our client and successfully concluded the transaction.

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Oct 23, 2026

Imagine a researcher using artificial intelligence to identify a new material, a pharmaceutical team using machine learning to discover a promising compound,

Can AI-Assisted Inventions Be Patented in India?
News & Updates, Thought Leadership
•
Oct 20, 2026

Every time someone publishes an article, uploads a photograph, releases a song or shares research online, they contribute to an expanding body of human

Who Owns Internet’s Knowledge? Copyright, AI Training and Indian Law
News & Updates, Thought Leadership
•
Oct 17, 2026

An active pharmaceutical ingredient (API) is the substance responsible for a medicine’s therapeutic effect. Developing one can involve years of chemical

API Process Patents in India: Key Patent Infringement Disputes and Court Decisions
Thought Leadership
•
Oct 15, 2026

First published on Enterprise IT World. Authored by Subroto Kumar Panda Imagine you gave a supersmart robot a credit card and told it to “buy the best

Taming the AI Beast: How Big Companies Build Safe AI Agents